Zentalis Pharmaceuticals (ZNTL) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to $7.0 million.
- Zentalis Pharmaceuticals' Interest & Investment Income fell 3737.89% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 4783.63%. This contributed to the annual value of $25.5 million for FY2024, which is 1276.47% up from last year.
- According to the latest figures from Q3 2025, Zentalis Pharmaceuticals' Interest & Investment Income is $7.0 million, which was down 3737.89% from $9.2 million recorded in Q2 2025.
- Over the past 5 years, Zentalis Pharmaceuticals' Interest & Investment Income peaked at $34.9 million during Q1 2024, and registered a low of -$22.9 million during Q2 2024.
- Moreover, its 4-year median value for Interest & Investment Income was $4.1 million (2023), whereas its average is $4.5 million.
- In the last 5 years, Zentalis Pharmaceuticals' Interest & Investment Income skyrocketed by 94976.42% in 2023 and then plummeted by 61365.99% in 2024.
- Over the past 4 years, Zentalis Pharmaceuticals' Interest & Investment Income (Quarter) stood at $3.2 million in 2022, then soared by 111.88% to $6.8 million in 2023, then plummeted by 68.28% to $2.2 million in 2024, then soared by 224.26% to $7.0 million in 2025.
- Its Interest & Investment Income stands at $7.0 million for Q3 2025, versus $9.2 million for Q2 2025 and -$2.7 million for Q1 2025.